Persistent bone marrow minimal residual disease as a "high-risk" disease feature in multiple myeloma

被引:3
作者
Mohan, Meera [1 ]
Szabo, Aniko [1 ]
Yarlagadda, Naveen [2 ]
Gundarlapalli, Sravani [3 ]
Thanendrarajan, Sharmilan [3 ]
Kendrick, Samantha [4 ]
Schinke, Carolina [3 ]
Alapat, Daisy [5 ]
Sawyer, Jeffrey [3 ]
Tian, Erming [3 ]
Tricot, Guido [3 ]
van Rhee, Frits [3 ]
Zangari, Maurizio [3 ]
机构
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[2] Univ Arkansas Med Sci, Div Hematol Oncol, Little Rock, AR 72205 USA
[3] Univ Arkansas Med Sci, Myeloma Ctr, 4301 W Markham St, Little Rock, AR 72223 USA
[4] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA
[5] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA
关键词
STEM-CELL TRANSPLANTATION; SURVIVAL OUTCOMES; MRD NEGATIVITY;
D O I
10.1002/ajh.26255
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E341 / E344
页数:4
相关论文
共 19 条
[1]   Evaluation of Sustained Minimal Residual Disease Negativity With Daratumumab-Combination Regimens in Relapsed and/or Refractory Multiple Myeloma: Analysis of POLLUX and CASTOR [J].
Avet-Loiseau, Herve ;
San-Miguel, Jesus ;
Casneuf, Tineke ;
Iida, Shinsuke ;
Lonial, Sagar ;
Usmani, Saad Z. ;
Spencer, Andrew ;
Moreau, Philippe ;
Plesner, Torben ;
Weisel, Katja ;
Ukropec, Jon ;
Chiu, Christopher ;
Trivedi, Sonali ;
Amin, Himal ;
Krevvata, Maria ;
Ramaswami, Priya ;
Qin, Xiang ;
Qi, Mia ;
Sun, Steven ;
Qi, Ming ;
Kobos, Rachel ;
Bahlis, Nizar J. .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (10) :1139-+
[2]   Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma [J].
Goicoechea, Ibai ;
Puig, Noemi ;
Cedena, Maria-Teresa ;
Burgos, Leire ;
Cordon, Lourdes ;
Vidriales, Maria-Belen ;
Flores-Montero, Juan ;
Gutierrez, Norma ;
Calasanz, Maria-Jose ;
Martin Ramos, Maria-Luisa ;
Lara-Astiaso, David ;
Vilas-Zornoza, Amaia ;
Alignani, Diego ;
Rodriguez, Idoia ;
Sarvide, Sarai ;
Alameda, Daniel ;
Jose Garces, Juan ;
Rodriguez, Sara ;
Fresquet, Vicente ;
Celay, Jon ;
Garcia-Sanz, Ramon ;
Martinez-Lopez, Joaquin ;
Oriol, Albert ;
Rios, Rafael ;
Martin-Sanchez, Jesus ;
Martinez-Martinez, Rafael ;
Sarra, Josep ;
Hernandez, Miguel-Teodoro ;
de la Rubia, Javier ;
Krsnik, Isabel ;
Moraleda, Jose-Maria ;
Palomera, Luis ;
Bargay, Joan ;
Angel Martinez-Climent, Jose ;
Orfao, Alberto ;
Rosinol, Laura ;
Mateos, Maria-Victoria ;
Lahuerta, Juan-Jose ;
Blade, Joan ;
San Miguel, Jesus ;
Paiva, Bruno .
BLOOD, 2021, 137 (01) :49-60
[3]   Primary refractory multiple myeloma: a real-world experience with 85 cases [J].
Jurczyszyn, Artur ;
Waszczuk-Gajda, Anna ;
Castillo, Jorge J. ;
Krawczyk, Katarzyna ;
Stork, Martin ;
Pour, Ludek ;
Usnarska-Zubkiewicz, Lidia ;
Potoczek, Stanislaw ;
Hus, Iwona ;
Davila Valls, Julio ;
Hari, Parameswaran ;
Chhabra, Saurabh ;
Gentile, Massimo ;
Mikala, Gabor ;
Varga, Gergely ;
Chim, Chor Sang ;
Fiala, Mark ;
Vij, Ravi ;
Schutz, Natalia ;
Rodzaj, Marek ;
Porowska, Agnieszka ;
Vesole, David H. ;
Druzd-Sitek, Agnieszka ;
Walewski, Jan ;
Nooka, Ajay K. .
LEUKEMIA & LYMPHOMA, 2020, 61 (12) :2868-2875
[4]   International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma [J].
Kumar, Shaji ;
Paiva, Bruno ;
Anderson, Kenneth C. ;
Durie, Brian ;
Landgren, Ola ;
Moreau, Philippe ;
Munshi, Nikhil ;
Lonial, Sagar ;
Blade, Joan ;
Mateos, Maria-Victoria ;
Dimopoulos, Meletios ;
Kastritis, Efstathios ;
Boccadoro, Mario ;
Orlowski, Robert ;
Goldschmidt, Hartmut ;
Spencer, Andrew ;
Hou, Jian ;
Chng, Wee Joo ;
Usmani, Saad Z. ;
Zamagni, Elena ;
Shimizu, Kazuyuki ;
Jagannath, Sundar ;
Johnsen, Hans E. ;
Terpos, Evangelos ;
Reiman, Anthony ;
Kyle, Robert A. ;
Sonneveld, Pieter ;
Richardson, Paul G. ;
McCarthy, Philip ;
Ludwig, Heinz ;
Chen, Wenming ;
Cavo, Michele ;
Harousseau, Jean-Luc ;
Lentzsch, Suzanne ;
Hillengass, Jens ;
Palumbo, Antonio ;
Orfao, Alberto ;
Rajkumar, S. Vincent ;
Miguel, Jesus San ;
Avet-Loiseau, Herve .
LANCET ONCOLOGY, 2016, 17 (08) :E328-E346
[5]   Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials [J].
Lahuerta, Juan-Jose ;
Paiva, Bruno ;
Vidriales, Maria-Belen ;
Cordon, Lourdes ;
Cedena, Maria-Teresa ;
Puig, Noemi ;
Martinez-Lopez, Joaquin ;
Rosinol, Laura ;
Gutierrez, Norma C. ;
Martin-Ramos, Maria-Luisa ;
Oriol, Albert ;
Teruel, Ana-Isabel ;
Echeveste, Maria-Asuncion ;
de Paz, Raquel ;
de Arriba, Felipe ;
Hernandez, Miguel T. ;
Palomera, Luis ;
Martinez, Rafael ;
Martin, Alejandro ;
Alegre, Adrian ;
De la Rubia, Javier ;
Orfao, Alberto ;
Mateos, Maria-Victoria ;
Blade, Joan ;
San-Miguel, Jesus F. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (25) :2900-+
[6]   Outcomes of primary refractory multiple myeloma and the impact of novel therapies [J].
Majithia, Neil ;
Rajkumar, S. Vincent ;
Lacy, Martha Q. ;
Buadi, Francis K. ;
Dispenzieri, Angela ;
Gertz, Morie A. ;
Hayman, Suzanne R. ;
Dingli, David ;
Kapoor, Prashant ;
Hwa, Lisa ;
Lust, John A. ;
Russell, Stephen J. ;
Go, Ronald S. ;
Kyle, Robert A. ;
Kumar, Shaji K. .
AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (11) :981-985
[7]  
Mohan M, 2020, BLOOD, V136, P11
[8]  
Mohan M, 2020, J CLIN ONCOL, V38
[9]   A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma [J].
Munshi, Nikhil C. ;
Avet-Loiseau, Herve ;
Anderson, Kenneth C. ;
Neri, Paola ;
Paiva, Bruno ;
Samur, Mehmet ;
Dimopoulos, Meletios ;
Kulakova, Margarita ;
Lam, Annette ;
Hashim, Mahmoud ;
He, Jianming ;
Heeg, Bart ;
Ukropec, Jon ;
Vermeulen, Jessica ;
Cote, Sarah ;
Bahlis, Nizar .
BLOOD ADVANCES, 2020, 4 (23) :5988-5999
[10]   Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma A Meta-analysis [J].
Munshi, Nikhil C. ;
Avet-Loiseau, Herve ;
Rawstron, Andy C. ;
Owen, Roger G. ;
Child, J. Anthony ;
Thakurta, Anjan ;
Sherrington, Paul ;
Samur, Mehmet Kemal ;
Georgieva, Anna ;
Anderson, Kenneth C. ;
Gregory, Walter M. .
JAMA ONCOLOGY, 2017, 3 (01) :28-35